TradeOrgs
  • Stocks
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← All stocks

🇮🇳AMRUTANJAN

AMRUTANJAN

NSE
₹538.40
▼ ₹8.15 (-1.5%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 03 Jul 2026
H ₹693.15L ₹486.00-21.1%
₹693.15₹651.72₹610.29₹568.86₹527.43₹486₹538.4
RSI (14)
Intraday · 15-minSell-15RSI 44DowntrendMACD Bullishfor day-trading context — not advice

Technical signal

Strong sell-70
RSI (14)44
oversold 30overbought 70
Trend
Downtrend
MACD
Bearish
Bollinger
Within bands
vs 20-day
below
vs 50-day
below
vs 200-day
below
Support
₹531.00
Resistance
₹577.45
  • Price is below its 50-day average (medium-term weakness).
  • MACD just crossed bearish (momentum turning down).

Signal backtest · 2025-09-29 → 2026-07-03

Strategy return
-15.7%
Buy & hold
-25.5%
Trades
6
Win rate
0%

₹1,00,000.00 invested would be worth ₹84,383.84 (-15.6%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Amrutanjan Health Care Limited· Drug Manufacturers - Specialty & Generic

source: yahoo

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn corn caps; hand sanitizer under the NOGerms brand name; and fruit and rehydration juice drinks under the Fruitnik brand name. The company also offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints, as well as provides sanitary napkins for women. In addition, it operates a pain management center. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Chennai, India
www.amrutanjan.com ↗

Fundamentals

source: yahoo
Market cap
₹1.56KCr
P/E
26.9
P/B
4.2
EPS
₹20.03
Div yield
1.0%
Profit margin
11.5%
ROE
16.6%
Debt / Equity
0.00
Beta
0.37
52-week range
₹486.00 – ₹790.95
52-week low · ₹486.0017% of rangehigh · ₹790.95

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:— Neutral1↑ · 1↓ · 6–
  • Tennessee deputy spent seized drug money on Apple gear for his family — now he owes $339K in pension clawbacks— Neutral
    Moneywise · 04 Jul 2026
  • Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done”— Neutral
    Insider Monkey · 04 Jul 2026
  • Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”▲ Positive
    Insider Monkey · 04 Jul 2026
  • Jim Cramer Says He Would Avoid Blue Owl and Prefers Blackstone

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

— Neutral
Insider Monkey · 04 Jul 2026
  • Jim Cramer on Palantir: “This Is the Fastest Grower of the Stocks I Follow, and It’s Been Crushed”— Neutral
    Insider Monkey · 04 Jul 2026
  • EPR's CFO Sold Shares at a Premium — Here's the Bet Behind the Stock— Neutral
    Motley Fool · 04 Jul 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.